Coordinated control of genome–nuclear lamina interactions by topoisomerase 2B and lamin B receptor
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Tom van Schaik und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: DNA Topoisomerases, Type II, Nuclear Lamina, Receptors, Cytoplasmic and Nuclear, Genome, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, NWO, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Lamina-associated domains (LADs) are megabase-sized genomic regions anchored to the nuclear lamina (NL). Factors controlling the interactions of the genome with the NL have largely remained elusive. Here, we identified DNA topoisomerase 2 beta (TOP2B) as a regulator of these interactions. TOP2B binds predominantly to inter-LAD (iLAD) chromatin and its depletion results in a partial loss of genomic partitioning between LADs and iLADs, suggesting that this enzyme might protect specific iLADs from interacting with the NL. TOP2B depletion affects LAD interactions with lamin B receptor (LBR) more than with lamins. LBR depletion phenocopies the effects of TOP2B depletion, despite the different positioning of the two proteins in the genome. This suggests a complementary mechanism for organizing the genome at the NL. Indeed, co-depletion of TOP2B and LBR causes partial LAD/iLAD inversion, reflecting changes typical of oncogene-induced senescence. We propose that a coordinated axis controlled by TOP2B in iLADs and LBR in LADs maintains the partitioning of the genome between the NL and the nuclear interior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
- Oncode Institute, The Netherlands.
- Division of Molecular Genetics, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
- Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
- Princess Maxima Center, 3584 CS Utrecht, The Netherlands.
- Institute of Molecular Biology gGmbH, 55128 Mainz, Germany.
ORCID-Profile: Elzo de Wit, René H Medema, Nick Gilbert, Bas van Steensel, Stefano G Manzo
Förderung
- European Union
- NWO
- Deutsche Forschungsgemeinschaft
- UK Medical Research Council
- MRC
- Dutch Cancer Society
- EU-MUR MSCA Young Researcher
Zitieren
APA
van Schaik, T., Magnitov, M., de Haas, M., Breda, J., de Wit, E., Manjon, A. G., Medema, R. H., Gothe, H. J., Roukos, V., Buckle, A. J., Naughton, C., Gilbert, N., van Steensel, B., & Manzo, S. G. (2025). Coordinated control of genome–nuclear lamina interactions by topoisomerase 2B and lamin B receptor. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf964
Vancouver
van Schaik T, Magnitov M, de Haas M, Breda J, de Wit E, Manjon AG, et al. Coordinated control of genome–nuclear lamina interactions by topoisomerase 2B and lamin B receptor. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf964
BibTeX
@article{vanSchaik2025,
author = {van Schaik, Tom and Magnitov, Mikhail and de Haas, Marcel and Breda, Jeremie and de Wit, Elzo and Manjon, Anna G and Medema, René H and Gothe, Henrike Johanna and Roukos, Vassilis and Buckle, Adam J and Naughton, Catherine and Gilbert, Nick and van Steensel, Bas and Manzo, Stefano G},
title = {Coordinated control of genome–nuclear lamina interactions by topoisomerase 2B and lamin B receptor},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf964}
}
EUVIMED